Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $42.9 million.

  • Acadia Healthcare Company's Restructuring Costs rose 42029.34% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.0 million, marking a year-over-year increase of 143548.45%. This contributed to the annual value of $46.8 million for FY2024, which is 8813.92% down from last year.
  • Latest data reveals that Acadia Healthcare Company reported Restructuring Costs of $42.9 million as of Q3 2025, which was up 42029.34% from $64.4 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Restructuring Costs high stood at $394.2 million for Q3 2023, and its period low was -$3.4 million during Q1 2024.
  • Over the past 5 years, Acadia Healthcare Company's median Restructuring Costs value was $6.3 million (recorded in 2023), while the average stood at $34.7 million.
  • As far as peak fluctuations go, Acadia Healthcare Company's Restructuring Costs soared by 352999.36% in 2023, and later crashed by 15254.21% in 2024.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Restructuring Costs stood at $3.5 million in 2021, then surged by 56.48% to $5.4 million in 2022, then soared by 7184.81% to $394.2 million in 2023, then crashed by 92.5% to $29.6 million in 2024, then soared by 45.16% to $42.9 million in 2025.
  • Its Restructuring Costs was $42.9 million in Q3 2025, compared to $64.4 million in Q2 2025 and $31.1 million in Q1 2025.